Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Pulmonary Hypertension

  Free Subscription


1 AIDS Rev
3 Am J Respir Cell Mol Biol
2 Am J Respir Crit Care Med
2 Ann Am Thorac Soc
1 Appl Biochem Biotechnol
1 BMC Pulm Med
1 BMJ Case Rep
1 Cardiovasc J Afr
3 Circulation
1 Comput Math Methods Med
1 Egypt Heart J
2 Eur Heart J
1 Eur Heart J Cardiovasc Imaging
1 Eur Respir J
1 Front Cardiovasc Med
1 Hell J Nucl Med
2 J Card Surg
2 J Nucl Cardiol
2 J Physiol
1 JACC Case Rep
2 Lancet Respir Med
1 Mol Med Rep
1 Pan Afr Med J
4 Pulm Circ
1 Rheumatology (Oxford)
1 Sci Rep
1 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AIDS Rev

  1. LIU Y, Han J, Li B, Xiao J, et al
    Risk factors associated with pulmonary arterial hypertension among HIV-infected adults: A meta-analysis and systematic review.
    AIDS Rev. 2022;24:59-68.
    PubMed         Abstract available

    Am J Respir Cell Mol Biol

  2. BONAFIGLIA QA, Zhou YQ, Hou G, Saha R, et al
    Deficiency in DDR1 Induces Pulmonary Hypertension and Impaired Alveolar Development.
    Am J Respir Cell Mol Biol. 2022 Aug 4. doi: 10.1165/rcmb.2022-0124.
    PubMed         Abstract available

  3. LE VELY B, Phan C, Berrebeh N, Thuillet R, et al
    Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
    Am J Respir Cell Mol Biol. 2022;67:215-226.
    PubMed         Abstract available

  4. BOGAARD HJ, Aman J
    Tyrosine Kinases and Endothelial Homeostasis in Pulmonary Arterial Hypertension: Too Hot to Handle?
    Am J Respir Cell Mol Biol. 2022;67:147-149.

    Am J Respir Crit Care Med

  5. YUAN P, Li J, Liu J, Liu H, et al
    Cognitive Dysfunction in Patients with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jul 29. doi: 10.1164/rccm.202204-0726.

  6. Erratum: Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Am J Respir Crit Care Med. 2022;206:362-363.

    Ann Am Thorac Soc

  7. SALEH D, Fisher JH, Provencher S, Liang Z, et al
    A Systematic Evaluation of the Quality, Accuracy, and Reliability of Internet Websites about Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2022;19:1404-1413.
    PubMed         Abstract available

  8. CIRULIS MM, Knox DB, Stoddard GJ, Brown LM, et al
    The CTEPH Trajectories Study: Assessment of Follow-Up after Acute Pulmonary Embolism to Identify Missed Opportunities for Chronic Thromboembolic Pulmonary Hypertension Diagnosis.
    Ann Am Thorac Soc. 2022;19:1428-1432.

    Appl Biochem Biotechnol

  9. XINTIAN, Zhang X, Feng Y, Gao X, et al
    Astragaloside IV in Hypoxic Pulmonary Hypertension: an In Vivo and In Vitro Experiments.
    Appl Biochem Biotechnol. 2022 Aug 2. pii: 10.1007/s12010-022-04027.
    PubMed         Abstract available

    BMC Pulm Med

  10. DONG X, Shi Y, Xia Y, Zhang X, et al
    Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.
    BMC Pulm Med. 2022;22:295.
    PubMed         Abstract available

    BMJ Case Rep

  11. ITAGAKI T, Miura T, Kasai T, Ikeda U, et al
    Symptomatic and severe pulmonary hypertension due to hyperthyroidism.
    BMJ Case Rep. 2022;15.
    PubMed         Abstract available

    Cardiovasc J Afr

  12. LI WT, Wu CW, Liu JM
    Association of changes in NT-proBNP, hsTnT and uric acid levels with haemodynamic changes after targeted medical therapies in patients with idiopathic pulmonary arterial hypertension.
    Cardiovasc J Afr. 2022;33:10-14.
    PubMed         Abstract available


  13. VEITH C, Ghofrani HA, Weissmann N
    Response by Veith et al to Letter Regarding Article, "SPARC, A Novel Regulator of Vascular Cell Function in Pulmonary Hypertension".
    Circulation. 2022;146:e16-e17.

  14. JIN Q, Guan L, Zhou D
    Letter by Jin et al Regarding Article, "SPARC, A Novel Regulator of Vascular Cell Function in Pulmonary Hypertension".
    Circulation. 2022;146:e14-e15.

  15. STEFFES LC, Cheng P, Quertermous T, Kumar ME, et al
    von Willebrand Factor Is Produced Exclusively by Endothelium, Not Neointima, in Occlusive Vascular Lesions in Both Pulmonary Hypertension and Atherosclerosis.
    Circulation. 2022;146:429-431.

    Comput Math Methods Med

  16. LI WJ, Wen ZP, Xing Y, Yang JP, et al
    HMGB1 Upregulates RAGE to Trigger the Expression of Inflammatory Factors in the Lung Tissue in a Hypoxic Pulmonary Hypertension Rat Model.
    Comput Math Methods Med. 2022;2022:6823743.
    PubMed         Abstract available

    Egypt Heart J

  17. AHMED AS, Divani GK, Gupta S
    A curious case of pulmonary hypertension in a child.
    Egypt Heart J. 2022;74:58.
    PubMed         Abstract available

    Eur Heart J

  18. DACHS TM, Duca F, Rettl R, Binder-Rodriguez C, et al
    Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
    Eur Heart J. 2022 Aug 1. pii: 6652608. doi: 10.1093.
    PubMed         Abstract available

  19. BAUERSACHS J, Olsson KM
    Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?
    Eur Heart J. 2022 Aug 1. pii: 6652609. doi: 10.1093.

    Eur Heart J Cardiovasc Imaging

  20. VAN DER BIJL P, Bax JJ
    Using deep learning to diagnose pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2022 Jul 30. pii: 6652181.

    Eur Respir J

  21. VAN DE VEERDONK MC, Vonk-Noordegraaf A, Vachiery JL
    Unbowed, unbent, unbroken: predicting pulmonary hypertension using echocardiography.
    Eur Respir J. 2022;60.

    Front Cardiovasc Med

  22. SCHWEINTZGER S, Kurath-Koller S, Burmas A, Grangl G, et al
    Normal Echocardiographic Reference Values of the Right Ventricular to Left Ventricular Endsystolic Diameter Ratio and the Left Ventricular Endsystolic Eccentricity Index in Healthy Children and in Children With Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:950765.
    PubMed         Abstract available

    Hell J Nucl Med

  23. YILMAZ F, Tuncez A, Onner H, Gedik GK, et al
    Diagnostic compatibility of V/Q SPECT and CTPA, which are non-invasive diagnostic methods, for the detection of CTEPH, which is a treatable cause of pulmonary hypertension.
    Hell J Nucl Med. 2022 Aug 3. pii: s002449912478. doi: 10.1967/s002449912478.
    PubMed         Abstract available

    J Card Surg

  24. PUJITHA V, Shaw M, Kumar S, Narang R, et al
    Delayed presentation of aorto-pulmonary window, double outlet right ventricle with pulmonary arterial hypertension: Illustration of uncommon association on dual-energy CT.
    J Card Surg. 2022;37:2852-2853.
    PubMed         Abstract available

  25. WANG Z, Ding N, Yi H, Zhu Y, et al
    Prognosis and related risk factors analysis of total anomalous pulmonary venous connection correction.
    J Card Surg. 2022;37:2524-2535.
    PubMed         Abstract available

    J Nucl Cardiol

  26. GONG JN, Chen BX, Xing HQ, Huo L, et al
    Pulmonary artery imaging with (68) Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension.
    J Nucl Cardiol. 2022 Aug 4. pii: 10.1007/s12350-022-03069.
    PubMed         Abstract available

  27. AKINCIOGLU C, Mehta S
    Nuclear imaging in chronic thromboembolic pulmonary hypertension: increasingly central to diagnosis and management.
    J Nucl Cardiol. 2022 Jul 18. pii: 10.1007/s12350-022-03056.

    J Physiol

  28. FUKUMITSU M, Vonk Noordegraaf A, Westerhof BE
    Reply from Masafumi Fukumitsu, Anton Vonk Noordegraaf and Berend E. Westerhof.
    J Physiol. 2022;600:3635.

  29. DANDEL M
    Pathophysiological insights with relevant impact on the prognostic assessment and clinical management of patients with pulmonary arterial hypertension.
    J Physiol. 2022;600:3633-3634.

    JACC Case Rep

  30. HANSMANN G, Sabiniewicz A, Sabiniewicz R
    Atrial Flow Regulator for Postcapillary Pulmonary Hypertension: First-in-Human Transcatheter AFR Device Implantations in RCM.
    JACC Case Rep. 2022;4:878-884.
    PubMed         Abstract available

    Lancet Respir Med

  31. KAWAKAMI T, Matsubara H, Shinke T, Abe K, et al
    Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial.
    Lancet Respir Med. 2022 Aug 1. pii: S2213-2600(22)00171.
    PubMed         Abstract available

  32. JAIS X, Brenot P, Bouvaist H, Jevnikar M, et al
    Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.
    Lancet Respir Med. 2022 Aug 1. pii: S2213-2600(22)00214.
    PubMed         Abstract available

    Mol Med Rep

  33. WU Q, Zhou X, Wang Y, Hu Y, et al
    LncRNA GAS5 promotes spermidineinduced autophagy through the miRNA315p/NAT8L axis in pulmonary artery endothelial cells of patients with CTEPH.
    Mol Med Rep. 2022;26.
    PubMed         Abstract available

    Pan Afr Med J

  34. OJO OE, Akintomide AO, Adebayo RA, Akinyele OA, et al
    Lutembacher syndrome presenting as heart failure in a young Nigerian at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife: a case report.
    Pan Afr Med J. 2022;41:342.
    PubMed         Abstract available

    Pulm Circ

  35. MAK S, Kolker S, Girdharry NR, Bentley RF, et al
    The role of exercise right heart catheterization to guide pulmonary hypertension therapy in older adults.
    Pulm Circ. 2022;12:e12103.
    PubMed         Abstract available

  36. ANDERSEN A, Hansen JV, Dragsbaek SJ, Maeng M, et al
    Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy.
    Pulm Circ. 2022;12:e12115.
    PubMed         Abstract available

  37. YU W, Dujiang X, Yi W, Guanwen D, et al
    Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure.
    Pulm Circ. 2022;12:e12096.
    PubMed         Abstract available

  38. GRINNAN D, Kang L, DeWilde C, Badesch D, et al
    Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.
    Pulm Circ. 2022;12:e12120.
    PubMed         Abstract available

    Rheumatology (Oxford)

  39. MARTIN CALDERON L, Chaudhary M, Pope JE
    Healthcare utilization and economic burden in systemic sclerosis: a systematic review.
    Rheumatology (Oxford). 2022;61:3123-3131.
    PubMed         Abstract available

    Sci Rep

  40. CARLSEN J, Henriksen HH, Marin de Mas I, Johansson PI, et al
    An explorative metabolomic analysis of the endothelium in pulmonary hypertension.
    Sci Rep. 2022;12:13284.
    PubMed         Abstract available

    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue

  41. XU X, Zhang J, Wang R, Zhang W, et al
    [Study on the effect of Xiaoqinglong decoction on vascular endothelin inpulmonary hypertension rat based on Jiebiaokuoluo method].
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022;34:597-601.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.